<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Reports 50% Revenue Growth for the Third Quarter of Fiscal Year 2016

February 8, 2016

- - -
Company Adds 98 New Biopharma Clients During First Nine Months of FY2016
- - -
58% Revenue Growth for the First Nine Months of FY2016
- - -
Full Year Revenue Guidance Revised

Irvine, CA – February 8, 2016 — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”) today announced financial results for the three and nine-month periods ended December 31, 2015.

Read More


Cryoport to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

February 4, 2016

Irvine, CA, Feb. 4, 2016 - Cryoport, Inc. (NASDAQ: CYRX), ("Company"), the world’s leading cryogenic logistics company, today announced that Jerrell Shelton, Chief Executive Officer of Cryoport, Inc, will present at the Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference to be held at the Convene, 730 Third Avenue in New York City on Wednesday, February 10, 2016 at 10:15am ET.

The event will be available via live audio webcast and archived replay accessible here.  

Read More


Cryoport to Report Third Quarter Fiscal 2016 Financial Results on February 8th

February 2, 2016

Irvine, Calif., Feb. 2, 2016 - Cryoport, Inc. (NASDAQ: CYRX), ("Company"), today announced that the Company will release financial results for the third quarter fiscal year 2016 ended December 31, 2015 on February 8, 2016 before the market opens.

Read More


Cryoport Introduces Its Advanced Cryogenic Logistics Solutions for IVF to the Cambodia and Czech Republic Markets

January 26, 2016

Irvine, CA, Jan. 26, 2016 - Cryoport, Inc. (NASDAQ: CYRX), ("Company"), the leading global cryogenic logistics company for the life sciences industry, today announced the geographic expansion of its Reproductive Medicine (IVF) shipping and logistics solutions to include Cambodia and the Czech Republic. 

Read More


Tags: IVF, global IVF, cryogenic frozen

CRYOPORT IS SELECTED BY MORPHOTEK TO MANAGE COLD CHAIN LOGISTICS

January 13, 2016

Shipments of proprietary technologies support the development of innovative new therapies for cancer, inflammation and infectious disease

Irvine, CA, and Exton, PA, Jan. 13, 2016 - Cryoport, Inc. (NASDAQ: CYRX), ("Company"), the world's leading cryogenic logistics company, and Morphotek® announced that Cryoport is providing end-to-end cold chain logistics support for shipments of Morphotek’s research and development materials.

Read More


Cryoport Announces Opening of New US Headquarters

December 9, 2015

New United States Headquarters and Operations Center Doubled in Size to Accommodate Increased Business and Solutions Development

IRVINE, Calif., Dec. 8, 2015 - Cryoport, Inc. (NASDAQ: CYRX) ("Company"), the world's leading cryogenic logistics company, today announced the opening of its new US headquarters in Irvine, CA. The purpose-built facility supports the Company's long-term expansion plans for its logistics operations and client-demanded scalability.

Read More


Cryoport Expands its Support of the Contract Research and Testing Arena

December 3, 2015

New client is key supplier of hepatocytes and other liver cell types supporting preclinical and clinical research

LAKE FOREST, Calif., Dec. 1, 2015 - Cryoport, Inc. (NASDAQ: CYRX) ("Company"), the world's leading cryogenic logistics company, today announced that Cryoport has been selected by QPS Hepatic Biosciences ("QPS-HB"), a subsidiary of QPS Holdings LLC ("QPS"), as its cryogenic logistics partner supporting QPS's cryopreserved hepatocytes businesses in the

Read More


Cryoport Revenues Climb 74% for the Second Quarter of Fiscal Year 2016

November 16, 2015

- - -
Company Adds Over 160 New Customers in First Half of FY2016
- - -
63% Revenue Growth for the First Half of FY2016; Full Year Revenue Guidance Confirmed

LAKE FOREST, CA – November 16, 2015 — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”) today announced financial results for the three and six-month periods ended September 30, 2015.

Read More


Cryoport Presenting at CAR-T Summit

November 11, 2015

(Lake Forest, Calif., Nov. 11, 2015) – Cryoport, Inc. (OTCBB: CYRX), the leading provider of advanced cryogenic logistics solution, is pleased to announce that Mark Sawicki, Ph.D., chief commercial officer, will speak alongside Robin Hooker, healthcare marketing director for UPS, at the CAR-T Summit in Boston at 3:30 p.m. Nov. 13, 2015.

Read More


Cryoport to Report Second Quarter Fiscal 2016 Financial Results

November 3, 2015

LAKE FOREST, California, November 3, 2015 - Cryoport, Inc. (NASDAQ: CYRX) (“Company”), today announced that the Company will release financial results for the second quarter fiscal year 2016 ended September 30, 2015 on Monday, November 16th before the market opens.

Read More